"Other reported side effects of Melanotan-II include nausea, vomiting, loss of appetite and abdominal pain
Oct 20: Nearly two years ago, the FDA approved BioMarins Voxzogo (vosoritide) as the first therapy for achondroplasia, a rare genetic disorder that causes the most common form of dwarfismfueling ongoing controversy within the dwarfism community about such treatments
This was highlighted in an experimental study performed on GLP-1-treated HL-1 cardiomyocytes, in which GLP1 increased calcium transients and sarcoplasmic reticular calcium contents by regulating the expression of calcium handling proteins, leading to a reduced calcium leak and thus preventing AF development [34]
This study demonstrates that GLP-1(2836) protects against cardiac ischemic injury
1 These were mostly mild symptoms that resolved quickly
Over the past decade, researchers have increasingly recognized the dual nature of BCAAs